Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE. (Q30679247)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE. |
scientific article |
Statements
1 reference
Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE. (English)
1 reference
W J Sandborn
1 reference
J-F Colombel
1 reference
R Panaccione
1 reference
G D'Haens
1 reference
Q Zhou
1 reference
P F Pollack
1 reference
R B Thakkar
1 reference
A M Robinson
1 reference
22 September 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference